Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren
Dma3.0
DMAA (1,3-Dimethylamylamin) – Forschung
Überwiegend Mechanismus / Beobachtung
6 begutachtete Studien
Was die Evidenz sagt
Überwiegend Mechanismus / Beobachtung
Die meisten Studien zu DMAA (1,3-Dimethylamylamin) sind mechanistisch oder beobachtend statt RCTs, die einen klinischen Effekt messen — betrachte die Ergebnisse als vorläufig.
Die meiste Evidenz stammt aus gemischt-qualitativen randomisierten Studien, veröffentlicht 2010–2018 mit einer typischen Studiengröße von 10 Teilnehmenden.
Basierend auf 6 Studien · 1 RCT · 10 Teilnehmende insgesamt
Konfidenz
Geringe Konfidenz
Nach Outcome
Heart, blood pressure & stroke
Überwiegend Mechanismus / Beobachtung6 Studien
Safety & toxicity
Überwiegend Mechanismus / Beobachtung5 Studien
Performance (claimed, unproven)
Überwiegend Mechanismus / Beobachtung3 Studien
Ältere Forschungsbasis
Neueste Studie von 2018
20102018
1Crossovern=10 · very small study2011
Acute ingestion of 1,3-dimethylamylamine alone and in combination with caffeine results in an increase in SBP, DBP, and RPP without an increase in HR.
Bloomer RJ, Harvey IC, Farney TM, Bell ZW, Canale RE · The Physician and sportsmedicine (2011)
Double-blind, randomized crossover in 10 healthy adults of caffeine and DMAA (geranamine) alone and combined
DMAA raised systolic and diastolic blood pressure and rate-pressure product dose-dependently — peak ~20% systolic rise with caffeine + 75 mg DMAA at 60 minutes
The best controlled human data on DMAA — it documents a blood-pressure rise (the harm mechanism), NOT any performance or fat-loss benefit
2Übersicht2017
There is a shallow evidence base describing the adverse effects of DMAA and the dose above which such effects may occur ... escalations of blood pressure were present on acute dosing.
Dunn M · The International journal on drug policy (2017)
Critical review of 16 studies — eight retrospective case reports of patients presenting to emergency departments and eight low-powered experimental studies
Several experimental studies came from a single research group with industry ties; the overall evidence base is shallow with no robust efficacy data
Acute dosing consistently escalated blood pressure — the one reproducible physiological signal
3Beobachtungsstudie2018
The United States Food and Drug Administration banned the stimulant 1,3-dimethylamylamine (1,3-DMAA) from dietary supplements and warned consumers that the stimulant can pose cardiovascular risks ranging from high blood pressure to heart attacks.
Documents the FDA ban of 1,3-DMAA from dietary supplements and the cardiovascular-risk warning (high blood pressure to heart attacks)
States 1,3-DMAA has been investigated as potentially contributing to hemorrhagic strokes and sudden death
Co-authored by the US Department of Defense's military-performance consortium — reflecting the military scrutiny that followed DMAA-linked soldier deaths
4Fallstudie2010
This case report describes a 21-year-old male who suffered a cerebral haemorrhage shortly after ingesting two capsules of DMAA.
Gee P, Jackson S, Easton J · The New Zealand medical journal (2010)
Mandatory counter-evidence: a 21-year-old man suffered a cerebral haemorrhage shortly after ingesting two DMAA capsules ('BZP-free party pills')
DMAA is a synthetic stimulant patented in the 1940s-50s as a nasal decongestant; little was known about its pharmacology by the ingested route
An early, defining case linking DMAA to catastrophic cerebrovascular harm in a young, otherwise healthy person
5Fallstudie2014
A previously healthy 22-year-old man ... was diagnosed with a non-ST-elevation myocardial infarction ... [after] ingesting the dietary supplements Jack3d (principal ingredient, 1,3-dimethylamylamine).
Smith TB, Staub BA, Natarajan GM, Lasorda DM, Poornima IG · Texas Heart Institute journal (2014)
A previously healthy 22-year-old man developed a non-ST-elevation myocardial infarction after ~3 weeks of Jack3d (DMAA) plus a Citrus aurantium product before exercise
Angiography showed a proximal LAD coronary thrombus with distal embolization, resolving on medical therapy
Counter-evidence: links the sympathomimetic DMAA-containing supplement to acute coronary harm in a young, healthy person
6Fallstudie2015
Adverse effects reported include cardiac arrest, hemorrhagic stroke, and death ... We describe a case of a young man who took such a supplement and suffered a cardiac arrest.
Karnatovskaia LV, Leoni JC, Freeman ML · Clinical journal of sport medicine (2015)
A young man suffered cardiac arrest after taking a DMAA-containing workout supplement
Notes that DMAA-containing products were determined illegal by the FDA yet remained widely available, marketed for performance and fat-burning
Reinforces the cardiac-arrest / hemorrhagic-stroke / death harm pattern and urges clinical suspicion in healthy young people presenting with cardiac arrest